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Hyperbilirubinemia is the most common abnormal physical finding in the 1st week of life and is observed in approximately 60% of term neonates and 80% of preterm 
neonates [1]. Bilirubin is potentially toxic to the central nervous 
system; phototherapy plays a significant role in the treatment 
and prevention of hyperbilirubinemia in neonates. Several 
adverse effects of phototherapy have also been reported [2]. 
A lesser-known but potential adverse effect of phototherapy 
is hypocalcemia. Most of the studies done till now had either 
observed serum total calcium levels or changes in ionic calcium 
with phototherapy [3,4] but did not observe them simultaneously. 
Hence, the present study was conducted to evaluate the effects of 
phototherapy on both total and ionic calcium levels.
METHODS
This case–control prospective study was conducted in the 
neonatal intensive care unit of the Department of Pediatrics, 
Umaid Hospital, Jodhpur (Rajasthan), over a period of 15 months 
after getting proper clearance from the Ethical Committee of our 
Institution. A proper consent was obtained from the parent(s) of 
newborns. All neonates preterm or term admitted from outside 
(extramural) or delivered at (intramural) Umaid Hospital with 
icterus in phototherapy range formed the study group(s).
Exclusion criteria were (a) newborns having, (i) icterus within 
24 h or more than 14 days, (ii) received sodium bicarbonate, 
(iii) history suggestive of birth asphyxia, (iv) neonatal septicemia, 
(v) respiratory distress syndrome, (vi) major or life-threatening 
congenital malformations, (vii) icterus in the range requiring 
exchange transfusion, and (viii) documented hypocalcemia at 
start of phototherapy. (b) Maternal and perinatal factors, (i) 
mother taken phenobarbitone during antenatal period, (ii) history 
of hyperthyroidism in mother, (iii) diabetic mother, and (iv) 
prolonged difficult labor. Phototherapy for management of 
hyperbilirubinemia in the healthy newborn was decided according 
to following guidelines [5] (Table 1).
Age, sex, and gestational age-matched hyperbilirubinemia 
neonates including term and preterm who did not fulfill the 
criteria for phototherapy were taken as the control group (c). 
After registration of these babies, detailed maternal and newborn-
related antenatal, natal and postnatal history was taken. General 
physical examination and systemic examination were performed. 
Gestational age was assessed by modified Parkin’s criteria.
All study group newborns received continuous double surface 
phototherapy with MEDITRIN. Double surface phototherapy 
unit has a combination of eight white and four blue tube lights at 
a distance of 45 cm. For effective phototherapy, it was checked 
that minimal spectral irradiance or flux of 4–6 µW/nm2 (at 425–
475nm) was available and maintained at the level of infant’s skin. 
Babies were kept naked except for diapers and eye bandage. 
The position of the infant was changed every 2 h. Parameters 
evaluated on serial basis were (daily): Total serum bilirubin 
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(direct and indirect) and serum calcium (Total and ionized). Serum 
bilirubin was done by Jendrassik and Grof method utilizing the 
reagent kit of Bayer diagnosis India Ltd. by bilirubin analyzer 
Erba chem - 5 plus Transasia. Indirect bilirubin was estimated 
by Vandenberg reaction. For quantitative estimation of calcium 
(total) in serum reagent, Arsenazo III was used, utilizing the kit of 
Ranbaxy laboratories limited by analyzer RA-50. For quantitative 
estimation of Ca+2, AVL electrolyte analyzer was used which was 
based on the principle of ion sensitive electrode measurement.
Phototherapy was discontinued when serum bilirubin levels 
reached 13.0±0.7 mg/dL in term and 10.7±1.2 mg/dL in preterm 
infants [2]. If bilirubin level had risen to the extent that exchange 
transfusion had to be done, case was excluded from the study. 
As we have compared two groups with continuous data (serum 
bilirubin and serum calcium) so matched pair t-test applied for 
statistical analysis. Qualitative data were analyzed by the χ2-test 
and Fisher’s exact test. The test is considered significant when 
p<0.05.
RESULTS
The present study included 78 neonates admitted in the neonatal 
intensive care unit. Among them, (66.7%) 52 neonates were 
with icterus in the phototherapy range formed the study group 
and (33.3%) 26 neonates age, sex and gestational age-matched, 
formed the control group. Among the study group, 53.8% were 
males and 46.2% were females. While in control group 57.7% 
were males and 42.3% were females. These two groups were 
statistically comparable (p>0.7).
Mean age at the time of enrollment in the study group was 
3.61±0.79 days and in control group was 3.71±0.61 days (p>0.6). 
In the study group out of 52, 67.3% (35) was term and 32.7% (17) 
were preterm while in control group out of 26, 69.3% (18) was 
term and 30.7% (8) were preterm. Difference was statistically 
insignificant (p>0.1). Most of the patients in study and control 
group (>92%) were appropriate for gestational age.
Neonates in the study group had a significant fall in total serum 
calcium after phototherapy (0.94±0.49 mg/dl). The difference was 
highly significant (p<0.001). The control group also had fall in 
total serum calcium, but it was statistically insignificant (p>0.9). 
Variation of pre and post total serum calcium value in the study 
and control group was highly significant (p<0.001). Similarly, 
ionized serum calcium also decreased after phototherapy in the 
study group (0.56±0.36 mg/dl, p<0.001) and was statistically 
significant while in control group levels did not change. Variation 
of pre- and post-ionized serum calcium value in the study and 
control group was highly significant (p<0.001) (Table 2).
In the study group fall in total serum calcium value increases 
with duration of phototherapy. However, the difference in fall was 
more between 24 h and 48 h duration. It was statistically highly 
significant (p<0.001). The fall in total serum calcium from 48 h 
to 72 h duration was statistically insignificant (p>0.5). Similarly, 
the fall in ionized serum calcium value increases with duration of 
phototherapy. Variation in total serum calcium and ionized serum 
calcium was studied at 48 h of enrollment, the study and control 
group values were compared which was statistically highly 
significant (p<0.001) (Tables 3 and 4).
Pre- and post-study variation of serum calcium (total and 
ionized) in both term and preterm babies and among study and 
control group was highly significant (p<0.001) (Table 5).
The overall incidence of hypocalcemia was 9.6%, higher in 
preterm 11.7% than term 8.5%. In study group overall, jitteriness 
Table 1: Guidelines for management of hyperbilirubinemia
Study population Weight Age Total serum bilirubin level
Term neonates ≥2.5 kg 25–48 h 15–19.99 mg/dl
49–72 h 18–24.99 mg/dl
>72 h 20–24.99 mg/dl
Preterm neonates 1000–1500 g 7–11.99 mg/dl
1500–2000 g 10–14.99 mg/dl
2000–2500 g 13–17.99 mg/dl
Table 2: Pre‑ and post‑study serum calcium




Statistical analysis t value p value
Total serum calcium (mg/dl)
Pre-study (a) 9.60±0.95 9.38±1.05 a versus b study group 4.66 <0.001
Post-study (b) 8.74±0.93 9.35±1.05 a versus b control group 0.10 >0.9
Variation (c) 0.94±0.49 0.03±0.08 Variation study versus control group 13.04 <0.001
Ionized serum 
calcium (mg/dl)
Pre-study (d) 4.89±0.49 4.69±0.47 d versus e study group 6.89 <0.001
Post-study (e) 4.32±0.34 4.70±0.48 d versus e control group 0.07 >0.9
Variation (f) 0.56±0.36 0.003±0.05 Variation study versus control group 10.94 <0.001
SD: Standard deviation
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and irritability both were seen in 25% of the neonates followed 
by irritability only (21.1%). Jitteriness only was seen in 23.5% 
preterm subgroup neonates while in term subgroup it was seen in 
only 11.4%. Both irritability and rashes were seen in 31.4% and 
11.7% of neonates in term and preterm subgroup, respectively. 
None of the neonate had a convulsion.
DISCUSSION
Most of the physiological function of the body requires an active 
form of calcium, i.e., ionized calcium. In the present study, 
ionized serum calcium levels had shown a significant fall in 
levels after phototherapy (p<0.001), in the same manner as total 
serum Calcium. Romagnoli et al. [6] noted the associated of 
hypocalcemia with the use of phototherapy. The results of our 
study agree with all the previously done work by different authors 
in relation to calcium and phototherapy and confirm the results of 
previous authors [7-14] (Table 6).
These observations indicate that duration of phototherapy 
has a definite correlation with disturbance (fall) in calcium 
level. Serum fall in calcium starts right from the beginning of 
phototherapy and relatively faster during first 48 h; thereafter, the 
fall is more gradual to attain any statistical significance.
Phototherapy induced hypocalcemia is not related to 
bilirubin metabolism. Phototherapy leads to inhibition of pineal 
gland through transcranial illumination, resulting in a decline 
in melatonin levels and, in turn, diminishing corticosterone 
to finally decrease calcium resorption from bones, producing 
hypocalcemia. Cortisol, unchecked, exerts a direct hypocalcemia 
effect and increase bone uptake of calcium as well [15]. Melatonin 
secretion normally starts around about 2–3 days after birth is less 
in premature babies increases over in childhood and again falls in 
adolescence and continues to decrease with aging. Phototherapy 
associated hypocalcemia can be prevented by occipital 
shielding [16], exogenous melatonin or inhibition of corticosteroid 
synthesis. Other causes suggested for this hypocalcemia include a 
decreased secretion of parathormone and higher urinary excretion 
of calcium in the phototherapy group [17]. Administration of 
25-hydroxyvitamin-D3 was not able to lower the incidence of 
the phototherapy-induced hypocalcemia in preterm infants and 
Table 3: Pre‑ and post‑study variation of serum calcium values in relation to duration of phototherapy










t value p value
Total serum calcium (mg/dl) 0.3±0.17 0.96±0.48 1.1±0.54 a versus b 5.82 <0.001
b versus c 0.83 >0.5
a versus c 3.82 <0.01
Ionized serum calcium (mg/dl) 0.26±0.15 0.52±0.3 0.84±0.53 a versus b 2.94 <0.01
b versus c 1.65 >0.2
a versus c 2.80 <0.02
SD: Standard deviation
Table 4: Pre‑ and post‑study variation of serum calcium after 48 h of enrollment
Variation of serum electrolytes Group t and P value
Study mean±SD Control mean±SD
Total serum calcium (mg/dl) 0.96±0.48 0.11±0.04 t 12.68, P<0.001
Ionized serum calcium (mg/dl) 0.52±0.3 0.02±0.04 t 11.81, P<0.001
SD: Standard deviation
Table 5: Gestational maturity versus pre‑ and post‑study variation of serum calcium values














Serum calcium total  
(mg/dl)
0.98±0.55 0.92±0.49 0.1±0 0.12±0.05 a versus b 0.38 >0.8
c versus d 1.69 >0.2
a versus c 6.59 <0.001
b versus d 9.56 <0.001
Serum calcium ionized 
(mg/dl)
0.56±0.36 0.55±0.37 0±0.06 0.02±0.05 a versus b 0.09 >0.9
c versus d 0.82 >0.5
a versus c 6.23 <0.001
b versus d 8.32 <0.001
SD: Standard deviation
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concluded that Vitamin D was unlikely to play an important role 
in the pathogenesis of phototherapy induced hypocalcemia.
Yadav et al. 2012 [3] observed symptoms of hypocalcemia 
were jitteriness, irritability, and lethargy but none had a 
convulsion. Bahbah et al. [11] and Rastogi [18] showed jitteriness 
as the most common symptom of hypocalcemia. Arora et al. [12] 
observed symptomatic hypocalcemia more in preterm than term. 
Since our study was a case–control study. Hence, it was difficult 
to generalize the findings of the study. Hence, further controlled 
trials on the same topic are proposed with a larger number of 
study subjects.
CONCLUSION
The fall in ionized serum calcium is responsible for the 
different clinical manifestation of hypocalcemia starting from 
irritability and jitteriness to frank convulsions. Although we 
did not find any case with convulsions, there is a possibility of 
developing convulsions in newborns if they are either premature 
or sick. Hence, monitoring of serum calcium level is very 
important before starting of phototherapy, especially in premature 
baby or a sick baby. An oral supplementation of calcium may be 
considered in newborns receiving phototherapy, however this 
need to be made clear further by few more studies.
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